In the article by the OBGYN Editors’ Integrity Group (OGEIG) entitled “Trustworthiness Criteria for Meta-Analyses of Randomized Controlled Studies: OBGYN Journal Guidelines” [Gynecol Obstet Invest. 2025;90:1–5, DOI: 10.1159/000541479], the following corrections are made:
Co-publication disclaimer was missing. The correct disclaimer should read: “This paper is being published simultaneously in the International Journal of Gynecology & Obstetrics, American Journal of Obstetrics & Gynecology-MFM, European Journal of Gynaecology & Obstetrics, Acta Obstetricia et Gynecologica Scandinavica, British Journal of Obstetrics & Gynaecology, Fertility & Sterility, Ultrasound in Obstetrics & Gynecology, and Gynecologic & Obstetric Investigation.”
The correct copyright text should read: “© 2024 The Authors. Published by John Wiley & Sons Ltd, Elsevier and S. Karger AG. By John Wiley & Sons Ltd on behalf of the International Federation of Gynecology and Obstetrics, the Nordic Federation of Societies of Obstetrics and Gynecology, and International Society of Ultrasound in Obstetrics and Gynecology, by Elsevier on behalf of the American Society for Reproductive Medicine.”
The original article has been corrected in order to reflect the changes.
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
